Flow-controlled ventilation in moderate acute respiratory distress syndrome due to COVID-19: an open-label repeated-measures controlled trial

被引：0
|
作者：
Eleni D. Van Dessel
Gregory R. De Meyer
Stuart G. Morrison
Philippe G. Jorens
Tom Schepens
机构：
[1] Antwerp University Hospital/University of Antwerp,Department of Critical Care Medicine
[2] Antwerp University Hospital/University of Antwerp,Department of Anesthesiology
来源：
Intensive Care Medicine Experimental | / 10卷
关键词：
COVID-19; ARDS; Flow-controlled ventilation; Mechanical ventilation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial
    Mohammad Bosaeed
    Ebrahim Mahmoud
    Ahmad Alharbi
    Hadeel Altayib
    Hawra Albayat
    Faisal Alharbi
    Khalid Ghalilah
    Abdulmajid Al Arfaj
    Jumana AlJishi
    Abdullatif Alarfaj
    Hajar Alqahtani
    Badriah M. Almutairi
    Manar Almaghaslah
    Nawaf M. Alyahya
    Abdullah Bawazir
    Saud AlEisa
    Abdulrahman Alsaedy
    Abderrezak Bouchama
    Malak Alharbi
    Majid AlShamrani
    Sameera Al Johani
    Majed Aljeraisy
    Mohammed Alzahrani
    Abdulhakeem O. Althaqafi
    Hassan Almarhabi
    Athari Alotaibi
    Nasser Alqahtani
    Yaseen M. Arabi
    Omar S. Aldibasi
    Ahmad Alaskar
    Infectious Diseases and Therapy, 2021, 10 : 2291 - 2307
  • [22] Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial
    Bosaeed, Mohammad
    Mahmoud, Ebrahim
    Alharbi, Ahmad
    Altayib, Hadeel
    Albayat, Hawra
    Alharbi, Faisal
    Ghalilah, Khalid
    Al Arfaj, Abdulmajid
    AlJishi, Jumana
    Alarfaj, Abdullatif
    Alqahtani, Hajar
    Almutairi, Badriah M.
    Almaghaslah, Manar
    Alyahya, Nawaf M.
    Bawazir, Abdullah
    AlEisa, Saud
    Alsaedy, Abdulrahman
    Bouchama, Abderrezak
    Alharbi, Malak
    AlShamrani, Majid
    Al Johani, Sameera
    Aljeraisy, Majed
    Alzahrani, Mohammed
    Althaqafi, Abdulhakeem O.
    Almarhabi, Hassan
    Alotaibi, Athari
    Alqahtani, Nasser
    Arabi, Yaseen M.
    Aldibasi, Omar S.
    Alaskar, Ahmad
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2291 - 2307
  • [23] Flow-controlled ventilation may reduce mechanical power and increase ventilatory efficiency in severe coronavirus disease-19 acute respiratory distress syndrome
    Grassetto, A.
    Pettenuzzo, T.
    Badii, F.
    Carlon, R.
    Sella, N.
    Navalesi, P.
    PULMONOLOGY, 2023, 29 (02): : 154 - 156
  • [24] Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial
    Saito, Sho
    Kutsuna, Satoshi
    Akifumi, Imamura
    Hase, Ryota
    Oda, Rentaro
    Terada, Junko
    Shimizu, Yosuke
    Uemura, Yukari
    Takamatsu, Yuki
    Yasuhara, Akemi
    Shiratori, Katsuyuki
    Satake, Masahiro
    Sakamoto, Naoya
    Miyazaki, Yasunari
    Shimizu, Hidefumi
    Togano, Tomiteru
    Matsunaga, Akihiro
    Okuma, Kazu
    Hamaguchi, Isao
    Fujisawa, Kyoko
    Nagashima, Maki
    Ashida, Shinobu
    Terada, Mari
    Kimura, Akiko
    Morioka, Shinichiro
    Matsubayashi, Keiji
    Tsuno, Nelson Hirokazu
    Kojima, Makiko
    Kuramitsu, Madoka
    Tezuka, Kenta
    Ikebe, Emi
    Ishizaka, Yukihito
    Kenji, Maeda
    Hangaishi, Akira
    Mikami, Ayako
    Sugiura, Wataru
    Ohmagari, Norio
    Mitsuya, Hiroaki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (09) : 869 - 874
  • [25] Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-Label Randomized Controlled Pilot Study
    Li, Ting
    Sun, Laifang
    Zhang, Wenwu
    Zheng, Chanfan
    Jiang, Chenchen
    Chen, Mingjing
    Chen, Di
    Dai, Zhijuan
    Bao, Shihui
    Shen, Xian
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (06): : 1096 - 1102
  • [26] Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial
    Singh, Harbans
    Yadav, Babita
    Rai, Amit K.
    Srivastava, Sumit
    Saiprasad, A. J., V
    Jameela, Sophia
    Singhal, Richa
    Muralidharan, Sanuj
    Mohan, Rijin
    Chaudhary, Shikha
    Rana, Rakesh
    Khanduri, Shruti
    Sharma, Bhagwan S.
    Chandrasekhararao, Bhogavalli
    Srikanth, Narayanam
    Dhiman, Kartar S.
    COMPLEMENTARY THERAPIES IN MEDICINE, 2023, 76
  • [27] Prone ventilation as treatment of acute respiratory distress syndrome related to COVID-19
    Petrone, Patrizio
    Brathwaite, Collin E. M.
    Joseph, D'Andrea K.
    EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY, 2021, 47 (04) : 1017 - 1022
  • [28] Prone ventilation as treatment of acute respiratory distress syndrome related to COVID-19
    Patrizio Petrone
    Collin E. M. Brathwaite
    D’Andrea K. Joseph
    European Journal of Trauma and Emergency Surgery, 2021, 47 : 1017 - 1022
  • [29] AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India
    Singh, Harbans
    Srivastava, Sumit
    Yadav, Babita
    Rai, Amit K.
    Jameela, Sophia
    Muralidharan, Sanuj
    Mohan, Rijin
    Chaudhary, Shikha
    Singhal, Richa
    Rana, Rakesh
    Khanduri, Shruti
    Sharma, Bhagwan S.
    Chandrasekhararao, Bhogavalli
    Srikanth, Narayanam
    Chaturvedi, Sarika
    COMPLEMENTARY THERAPIES IN MEDICINE, 2022, 66
  • [30] A case report of individualized ventilation in a COVID-19 patient – new possibilities and caveats to consider with flow-controlled ventilation
    Patrick Spraider
    Gabriel Putzer
    Robert Breitkopf
    Julia Abram
    Simon Mathis
    Bernhard Glodny
    Judith Martini
    BMC Anesthesiology, 21
12345